AXS Cannabis ETF
THCX
THCX was delisted on the 21st of February, 2024.
11 hedge funds and large institutions have $1.4M invested in AXS Cannabis ETF in 2019 Q3 according to their latest regulatory filings, with 11 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.1M |
| 2 |
Jane Street
New York
|
+$320K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$312K |
| 4 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$15.5K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14.6K |
Top Sellers
THCX Hedge Fund Activity: Q3 2019 in Review
11 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in AXS Cannabis ETF (THCX) for Q3 2019, worth a combined $1.4M.
Buyers outnumbered sellers: 11 funds opened new THCX positions and 0 closed out — a net gain of 11 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $1.1M.
- 11 institutional investors held AXS Cannabis ETF (THCX) as of Q3 2019, up from 0 in Q2 2019.
- Funds reported $1.4M of AXS Cannabis ETF stock for Q3 2019.
- 11 funds opened new AXS Cannabis ETF positions in Q3 2019 and 0 closed out, a net change of +11 holders.
- The largest AXS Cannabis ETF buyer in Q3 2019 was Susquehanna International Group, an estimated $1.1M added.
Based on aggregated 13F filings for Q3 2019.